KOVAI

Kovai Medical Center & Hospital share price & financials

Price
₹5,986
Market cap
₹6.8k Cr
Sector
Healthcare

What Kovai Medical Center & Hospital Limited does

Kovai Medical Center and Hospital Limited (KMCH) operates a multi-speciality hospital business centred in Coimbatore, Tamil Nadu, earning revenue from in-patient and out-patient clinical services across specialities such as cardiology, oncology, neurology, urology, ENT, gynaecology, paediatrics, gastroenterology and haematology, including kidney and liver transplant programs. The group grew from a 250-bed facility about 35 years ago into a 2,000-bed hospital and also runs the Sulur Multi-Speciality Hospital as a second campus. It has diversified into medical education, running an affiliated medical college alongside the hospital, and offers nursing, dietary and allied health sciences training.

Bed capacity (main campus)
2,000 beds
Hospital campuses
Main Coimbatore campus plus the Sulur Multi-Speciality Hospital campus
Accreditation
NABH-accredited (National Accreditation Board for Hospitals and Healthcare Providers)
Affiliated medical education institution
Operates its own medical college alongside the hospital, plus nursing, dietary and allied health sciences courses
Clinical specialities
Multi-speciality care spanning cardiology, oncology, neurology, urology, ENT, gynaecology, paediatrics, gastroenterology and haematology, plus emergency care
Transplant programs
Kidney transplant and liver transplant programs
Founded 1985Headquarters Coimbatore, Tamil Nadu, IndiaEmployees 5,992 (2025-03-31) Company website

Quarterly results

Q1 FY27: revenue up 15.2%, net profit up 21.1% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue344 355 357 374 392 +14%407 +15%414 +16%431 +15%
EBITDA96 103 101 106 107 +11%116 +13%111 +10%124 +17%
Net profit51 58 55 57 59 +16%65 +12%63 +15%69 +21%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance +140.8% 1Y

₹3.0k₹4.0k₹5.0k₹6.0kOct 23Apr 26Aug 26

1Y: ₹2,576.65 on 25 Oct 2023 → ₹6,203.5. High ₹6,292 (10 Sept 2026), low ₹2,576.65 (25 Oct 2023).

Financials, as filed

Revenue grew 15.9% a year over 3 years, FY23 to FY26. Operating margin widened to 27.7%.

Year endingFY23FY24FY25FY26
Revenue₹1.0k Cr₹1.2k Cr₹1.4k Cr₹1.6k Cr
Operating profit₹268 Cr₹341 Cr₹386 Cr₹440 Cr
Operating margin26.3%28.0%28.2%27.7%
Interest₹40 Cr₹32 Cr₹33 Cr₹32 Cr
Depreciation₹89 Cr₹92 Cr₹98 Cr₹110 Cr
Net profit₹116 Cr₹179 Cr₹210 Cr₹244 Cr
Net margin11.4%14.7%15.3%15.4%
Cash from operations₹263 Cr₹344 Cr₹335 Cr₹362 Cr
Free cash flow₹136 Cr₹206 Cr₹-18 Cr₹111 Cr
ROCE17.0%23.0%23.0%23.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹11 Cr₹11 Cr₹11 Cr₹11 Cr₹11 Cr₹11 Cr
Reserves₹499 Cr₹598 Cr₹708 Cr₹878 Cr₹1.2k Cr₹1.3k Cr
Borrowings₹623 Cr₹550 Cr₹511 Cr₹310 Cr₹399 Cr₹403 Cr
Other liabilities₹148 Cr₹184 Cr₹209 Cr₹240 Cr₹328 Cr₹345 Cr
Total liabilities₹1.3k Cr₹1.3k Cr₹1.4k Cr₹1.4k Cr₹1.9k Cr₹2.1k Cr
Fixed assets₹1.0k Cr₹1.1k Cr₹1.1k Cr₹1.1k Cr₹1.3k Cr₹1.5k Cr
Capital work in progress₹45 Cr₹5 Cr₹23 Cr₹39 Cr₹224 Cr₹135 Cr
Investments₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
Other assets₹203 Cr₹253 Cr₹328 Cr₹282 Cr₹406 Cr₹458 Cr
Total assets₹1.3k Cr₹1.3k Cr₹1.4k Cr₹1.4k Cr₹1.9k Cr₹2.1k Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, the public added +0.33 pp while DIIs trimmed −0.28 pp. The shareholder count grew 10% to 19,362.

Promoters
56.5%
FIIs
1.3%
DIIs
4.2%
Public
38.0%

Since Jun 2025

  • Public +0.33 pp
  • DIIs −0.28 pp
  • Promoters −0.02 pp

How it drifted, 12 quarters

Over this window DIIs went from 2.1% to 4.2% — +2.1 pp.

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 56.4%, FIIs 2.3%, DIIs 2.1%, Public 39.2%.Dec '23: Promoters 56.4%, FIIs 2.2%, DIIs 2.1%, Public 39.2%.Mar '24: Promoters 56.5%, FIIs 0.3%, DIIs 4.2%, Public 39.0%.Jun '24: Promoters 56.5%, FIIs 0.3%, DIIs 4.3%, Public 38.9%.Sep '24: Promoters 56.5%, FIIs 0.4%, DIIs 4.4%, Public 38.7%.Dec '24: Promoters 56.5%, FIIs 0.6%, DIIs 4.4%, Public 38.5%.Mar '25: Promoters 56.5%, FIIs 1.1%, DIIs 4.0%, Public 38.3%.Jun '25: Promoters 56.5%, FIIs 1.3%, DIIs 4.5%, Public 37.6%.Sep '25: Promoters 56.5%, FIIs 1.3%, DIIs 4.9%, Public 37.3%.Dec '25: Promoters 56.5%, FIIs 1.3%, DIIs 4.7%, Public 37.4%.Mar '26: Promoters 56.5%, FIIs 1.2%, DIIs 4.5%, Public 37.8%.Jun '26: Promoters 56.5%, FIIs 1.3%, DIIs 4.2%, Public 38.0%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 2 holders trimming and 1 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of Kovai Medical Center & Hospital Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

What the price assumes

Attractive

To justify its price of ₹6204, this stock must grow earnings at 19% every year for 7 years. Our analysis caps realistic growth at ~28%. At that growth it is worth ₹10150 — upside of 64%.

Growth the price implies
18.6% a year
for 7 years, fading to 4%
It has actually compounded at
28.1% a year
net profit, FY23–FY26 · EPS 28.3%
The gap
-0.1 pp
64% downside if it only repeats history
Price today ₹6,203.5 Value at the reference growth ₹10,150.11

Change the assumptions yourself →